Extracorporeal CO2 Removal Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
체외식 CO2 제거 시장 - 보고서 범위
TMR의 세계 체외식 CO2 제거 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023-2031년 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻을 수 있는 기회를 조사합니다. 이 보고서는 2017-2031년 기간 동안 시장을 분석하여 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 전 세계 체외식 CO2 제거의 수익을 제공합니다. 또한 2023-2031년 세계 체외식 CO2 제거 시장의 연평균 성장률(CAGR %)도 제공합니다.
이 보고서는 광범위한 연구를 통해 작성되었습니다. 1차 조사에서는 분석가들이 주요 오피니언 리더, 업계 리더 및 오피니언 메이커를 인터뷰하여 주요 연구 활동의 대부분을 수행했으며, 2차 조사에서는 체외식 CO2 제거 시장을 이해하기 위해 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조를 포함합니다.
이 보고서는 세계 체외식 CO2 제거 시장의 경쟁 구도를 심층적으로 분석합니다. 세계 체외식 CO2 제거 시장에서 활동하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성 측면에서 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT는 이 보고서에 소개된 세계 체외식 CO2 제거 시장 기업의 속성입니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
- 소개
- 개요
- 시장 역학
- 세계 시장 분석과 예측(2017-2031년)
제5장 중요한 인사이트
- 파이프라인 분석
- 주요 제품/브랜드 분석
- 주요 인수합병
- COVID-19 팬데믹이 업계에 미치는 영향
제6장 세계 시장 분석과 예측 : 제품별
- 소개와 정의
- 주요 조사 결과/발전
- 시장 금액 예측 : 제품별(2017-2031년)
- 체외식 CO2 기기
- 소모품
- 가스 교환 유닛
- 액세스 캐뉼라
- 시장 매력도 : 제품별
제7장 세계 시장 분석과 예측 : 용도별
- 소개와 정의
- 주요 조사 결과/발전
- 시장 금액 예측 : 용도별(2017-2031년)
- 만성폐쇄성폐질환(COPD)
- 급성 호흡곤란 증후군(ARDS)
- BTT
- 기타
- 시장 매력도 : 용도별
제8장 세계 시장 분석과 예측 : 액세스 유형별
- 소개와 정의
- 주요 조사 결과/발전
- 시장 금액 예측 : 액세스 유형별(2017-2031년)
- 시장 매력도 : 액세스 유형별
제9장 세계 시장 분석과 예측 : 최종사용자별
- 소개와 정의
- 주요 조사 결과/발전
- 시장 금액 예측 : 최종사용자별(2017-2031년)
- 시장 매력도 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
- 주요 조사 결과
- 시장 금액 예측 : 지역별(2017-2031년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- 시장 매력도 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 상황
- 시장 기업 : 경쟁 매트릭스(기업 계층·규모별)
- 시장 점유율 분석 : 기업별(2022년)
- 기업 개요
- Alung Technologies Inc.
- XENIOS AG
- Medica SpA
- Estor SpA
- Medtronic plc
- Getinge AB
- Aferetica srl
ksm
Extracorporeal CO2 Removal Market - Scope of Report
TMR's report on the global extracorporeal CO2 removal market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global extracorporeal CO2 removal market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global extracorporeal CO2 removal market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the extracorporeal CO2 removal market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global extracorporeal CO2 removal market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global extracorporeal CO2 removal market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global extracorporeal CO2 removal market.
The report delves into the competitive landscape of the global extracorporeal CO2 removal market. Key players operating in the global extracorporeal CO2 removal market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global extracorporeal CO2 removal market profiled in this report.
Key Questions Answered in Global extracorporeal CO2 removal Market Report:
- What is the sales/revenue generated by extracorporeal CO2 removal across all regions during the forecast period?
- What are the opportunities in the global extracorporeal CO2 removal market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Extracorporeal CO2 Removal Market - Research Objectives and Research Approach
The comprehensive report on the global extracorporeal CO2 removal market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global extracorporeal CO2 removal market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global extracorporeal CO2 removal market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Extracorporeal CO2 Removal Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Extracorporeal CO2 Removal Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Key Product/Brand Analysis
- 5.3. Key Mergers & Acquisitions
- 5.4. COVID-19 Pandemic Impact on Industry
6. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Product
- 6.1. Introduction and Definitions
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Extracorporeal CO2 Machines
- 6.3.2. Disposables
- 6.3.3. Gas Exchange Units
- 6.3.4. Access Cannulas
- 6.4. Market Attractiveness, by Product
7. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Application
- 7.1. Introduction and Definitions
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Chronic Obstructive Pulmonary Disease (COPD)
- 7.3.2. Acute Respiratory Distress Syndrome (ARDS)
- 7.3.3. Bridge to Transplant
- 7.3.4. Others
- 7.3.5. 7.4 Market Attractiveness, by Application
8. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Access Type
- 8.1. Introduction and Definitions
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by Access Type, 2017-2031
- 8.3.1. Venovenous
- 8.3.2. Arteriovenous
- 8.4. Market Attractiveness, by Access Type
9. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by End-user
- 9.1. Introduction and Definitions
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospital
- 9.3.2. Surgical Centers
- 9.3.3. Others
- 9.4. Market Attractiveness, by End-user
10. Global Extracorporeal CO2 Removal Market Analysis and Forecast, by Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region, 2017-2031
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
- 10.3. Market Attractiveness, by Region
11. North America Extracorporeal CO2 Removal Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Extracorporeal CO2 Machines
- 11.2.2. Disposables
- 11.2.3. Gas Exchange Units
- 11.2.4. Access Cannulas
- 11.3. Market Attractiveness, by Product
- 11.4. Market Value Forecast, by Application, 2017-2031
- 11.4.1. Chronic Obstructive Pulmonary Disease (COPD)
- 11.4.2. Acute Respiratory Distress Syndrome (ARDS)
- 11.4.3. Bridge to Transplant
- 11.4.4. Others
- 11.5. Market Attractiveness, by Application
- 11.6. Market Value Forecast, by Access Type, 2017-2031
- 11.6.1. Venovenous
- 11.6.2. Arteriovenous
- 11.7. Market Attractiveness, by Access Type
- 11.8. Market Value Forecast, by End-user, 2017-2031
- 11.8.1. Hospital
- 11.8.2. Surgical Centers
- 11.8.3. Others
- 11.9. Market Attractiveness, by End-user
- 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.10.1. U.S.
- 11.10.2. Canada
- 11.11. Market Attractiveness Analysis
- 11.11.1. By Product
- 11.11.2. By Application
- 11.11.3. By Access Type
- 11.11.4. By End-user
- 11.11.5. By Country
12. Europe Extracorporeal CO2 Removal Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Extracorporeal CO2 Machines
- 12.2.2. Disposables
- 12.2.3. Gas Exchange Units
- 12.2.4. Access Cannulas
- 12.3. Market Attractiveness, by Product
- 12.4. Market Value Forecast, by Application, 2017-2031
- 12.4.1. Chronic Obstructive Pulmonary Disease (COPD)
- 12.4.2. Acute Respiratory Distress Syndrome (ARDS)
- 12.4.3. Bridge to Transplant
- 12.4.4. Others
- 12.5. Market Attractiveness, by Application
- 12.6. Market Value Forecast, by Access Type, 2017-2031
- 12.6.1. Venovenous
- 12.6.2. Arteriovenous
- 12.7. Market Attractiveness, by Access Type
- 12.8. Market Value Forecast, by End-user, 2017-2031
- 12.8.1. Hospital
- 12.8.2. Surgical Centers
- 12.8.3. Others
- 12.9. Market Attractiveness, by End-user
- 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.10.1. Germany
- 12.10.2. U.K.
- 12.10.3. France
- 12.10.4. Italy
- 12.10.5. Spain
- 12.10.6. Rest of Europe
- 12.11. Market Attractiveness Analysis
- 12.11.1. By Product
- 12.11.2. By Application
- 12.11.3. By Access Type
- 12.11.4. By End-user
- 12.11.5. By Country/Sub-region
13. Asia Pacific Extracorporeal CO2 Removal Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Extracorporeal CO2 Machines
- 13.2.2. Disposables
- 13.2.3. Gas Exchange Units
- 13.2.4. Access Cannulas
- 13.3. Market Attractiveness, by Product
- 13.4. Market Value Forecast, by Application, 2017-2031
- 13.4.1. Chronic Obstructive Pulmonary Disease (COPD)
- 13.4.2. Acute Respiratory Distress Syndrome (ARDS)
- 13.4.3. Bridge to Transplant
- 13.4.4. Others
- 13.5. Market Attractiveness, by Application
- 13.6. Market Value Forecast, by Access Type, 2017-2031
- 13.6.1. Venovenous
- 13.6.2. Arteriovenous
- 13.7. Market Attractiveness, by Access Type
- 13.8. Market Value Forecast, by End-user, 2017-2031
- 13.8.1. Hospital
- 13.8.2. Surgical Centers
- 13.8.3. Others
- 13.9. Market Attractiveness, by End-user
- 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.10.1. China
- 13.10.2. Japan
- 13.10.3. India
- 13.10.4. Australia & New Zealand
- 13.10.5. Rest of Asia Pacific
- 13.11. Market Attractiveness Analysis
- 13.11.1. By Product
- 13.11.2. By Application
- 13.11.3. By Access Type
- 13.11.4. By End-user
- 13.11.5. By Country/Sub-region
14. Latin America Extracorporeal CO2 Removal Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Extracorporeal CO2 Machines
- 14.2.2. Disposables
- 14.2.3. Gas Exchange Units
- 14.2.4. Access Cannulas
- 14.3. Market Attractiveness, by Product
- 14.4. Market Value Forecast, by Application, 2017-2031
- 14.4.1. Chronic Obstructive Pulmonary Disease (COPD)
- 14.4.2. Acute Respiratory Distress Syndrome (ARDS)
- 14.4.3. Bridge to Transplant
- 14.4.4. Others
- 14.5. Market Attractiveness, by Application
- 14.6. Market Value Forecast, by Access Type, 2017-2031
- 14.6.1. Venovenous
- 14.6.2. Arteriovenous
- 14.7. Market Attractiveness, by Access Type
- 14.8. Market Value Forecast, by End-user, 2017-2031
- 14.8.1. Hospital
- 14.8.2. Surgical Centers
- 14.8.3. Others
- 14.9. Market Attractiveness, by End-user
- 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.10.1. Brazil
- 14.10.2. Mexico
- 14.10.3. Rest of Latin America
- 14.11. Market Attractiveness Analysis
- 14.11.1. By Product
- 14.11.2. By Application
- 14.11.3. By Access Type
- 14.11.4. By End-user
- 14.11.5. By Country/Sub-region
15. Middle East & Africa Extracorporeal CO2 Removal Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Extracorporeal CO2 Machines
- 15.2.2. Disposables
- 15.2.3. Gas Exchange Units
- 15.2.4. Access Cannulas
- 15.3. Market Attractiveness, by Product
- 15.4. Market Value Forecast, by Application, 2017-2031
- 15.4.1. Chronic Obstructive Pulmonary Disease (COPD)
- 15.4.2. Acute Respiratory Distress Syndrome (ARDS)
- 15.4.3. Bridge to Transplant
- 15.4.4. Others
- 15.5. Market Attractiveness, by Application
- 15.6. Market Value Forecast, by Access Type, 2017-2031
- 15.6.1. Venovenous
- 15.6.2. Arteriovenous
- 15.7. Market Attractiveness, by Access Type
- 15.8. Market Value Forecast, by End-user, 2017-2031
- 15.8.1. Hospital
- 15.8.2. Surgical Centers
- 15.8.3. Others
- 15.9. Market Attractiveness, by End-user
- 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.10.1. GCC Countries
- 15.10.2. South Africa
- 15.10.3. Rest of Middle East & Africa
- 15.11. Market Attractiveness Analysis
- 15.11.1. By Product
- 15.11.2. By Application
- 15.11.3. By Access Type
- 15.11.4. By End-user
- 15.11.5. By Country/Sub-region
16. Competition Landscape
- 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 16.2. Market Share Analysis, by Company (2022)
- 16.3. Company Profiles
- 16.3.1. Alung Technologies Inc.
- 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.1.2. Product Portfolio
- 16.3.1.3. Financial Overview
- 16.3.1.4. SWOT Analysis
- 16.3.1.5. Strategic Overview
- 16.3.2. XENIOS AG
- 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.2.2. Product Portfolio
- 16.3.2.3. Financial Overview
- 16.3.2.4. SWOT Analysis
- 16.3.2.5. Strategic Overview
- 16.3.3. Medica SpA
- 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.3.2. Product Portfolio
- 16.3.3.3. Financial Overview
- 16.3.3.4. SWOT Analysis
- 16.3.3.5. Strategic Overview
- 16.3.4. Estor SpA
- 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.4.2. Product Portfolio
- 16.3.4.3. Financial Overview
- 16.3.4.4. SWOT Analysis
- 16.3.4.5. Strategic Overview
- 16.3.5. Medtronic plc
- 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.5.2. Product Portfolio
- 16.3.5.3. Financial Overview
- 16.3.5.4. SWOT Analysis
- 16.3.5.5. Strategic Overview
- 16.3.6. Getinge AB
- 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.6.2. Product Portfolio
- 16.3.6.3. Financial Overview
- 16.3.6.4. SWOT Analysis
- 16.3.6.5. Strategic Overview
- 16.3.7. Aferetica s.r.l.
- 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 16.3.7.2. Product Portfolio
- 16.3.7.3. Financial Overview
- 16.3.7.4. SWOT Analysis
- 16.3.7.5. Strategic Overview
